Evaluation of the impact of shielding to avoid COVID-19 infection on
                        respiratory symptoms in children with severe asthma

Gajaweera, Hasitha; Oladele, Damilola M; Connett, Gary

doi:10.1136/archdischild-2020-320498

Cited by 4 publications

(3 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Similarly, Gajaweera et al reported a case series of 58 patients, in which 48% of the children self-reported better control of asthma than they had during the same period in the previous year. 14 The primary reasons were fewer infections and less exposure to pollen due to lockdown.…”

Section: Asthma Control and Severity During The Covid-19 Pandemicmentioning

confidence: 99%

Effect of the SARS-CoV-2 pandemic on the control and severity of pediatric asthma

Sánchez‐García

Ruíz-Hornillos

Bernaola-Abraira

et al. 2022

aei

View full text Add to dashboard Cite

Background: The novel disease caused by the new coronavirus SARS-CoV-2 has caused an unprecedented global pandemic. Care providers of asthmatic children are increasingly con-cerned; as viral infections are one of the primary triggers of asthma flare-up. However, the effect of SARS-CoV-2 as well as the generated worldwide lockdown on asthmatic children is unknown.Objective: The aim of this study was to analyze the effects of pandemic SARS-CoV-2 in pediat-ric asthma control.Material and Methods: A retrospective, open, transversal study was performed at five tertiary hospitals. Recruited patients were aged <18 years and had physician-diagnosed asthma. Information regarding the 2019 and 2020 seasons were provided.Results: Data were collected from 107 children (age range: 3–18 years, mean age: 12 years). Well-controlled asthma was observed in 58 (54.2%) patients in 2020 versus 30 (28%) in 2019, and 15 (14%) patients had poorly controlled asthma in 2020 versus 28 (26.2%) in 2019. In 2020, a decrease in exacerbations caused by allergies to pollen, dust mites, molds, and through other causes not related to SARS-CoV-2 infection was observed. An increase in exacerbations was observed due to animal dander, stress, physical exercise, and SARS-CoV-2 infection. Children had a reduced need for asthma-controlling medication, made fewer visits to healthcare pro-viders and had lesser need of treatment with oral corticosteroids if compared with the same season of 2019.Conclusion: Pediatric asthma control improved, the need for controller medication declined, and fewer visits to healthcare providers were made during the pandemic if compared with the 2019 season.

show abstract

Section: Asthma Control and Severity During The Covid-19 Pandemicmentioning

confidence: 99%

Effect of the SARS-CoV-2 pandemic on the control and severity of pediatric asthma

Sánchez‐García

Ruíz-Hornillos

Bernaola-Abraira

et al. 2022

aei

View full text Add to dashboard Cite

show abstract

“…Many patients also reported better asthma control. 11,[18][19][20] Nevertheless, some people with asthma may have experienced an increase in asthma symptoms owing to increased use of disinfectants. 21 Survey studies have found an increase in anxiety, depression, asthma symptoms, decreased symptom control, and QoL (Table 1).…”

Section: Asthmamentioning

confidence: 99%

Psychological impacts of coronavirus disease 2019 on people with asthma, allergic rhinitis, and food allergy

Burrows

Ellis

2022

Annals of Allergy, Asthma & Immunology

View full text Add to dashboard Cite

To summarize the current literature of the psychological impacts of coronavirus disease 2019 (COVID-19) on people with allergic diseases and to identify gaps in need of future research. Data Sources: Ovid MEDLINE(R) and Embase Classics + Embase from 1947 to present (October 18, 2021) were searched using a search strategy that included the following keywords: allergic diseases, covid*, and psychological disorders. Study Selections: Primary manuscripts and abstracts using online and telephone surveys, mixed-method studies capturing patient and caregiver experiences, case studies, and published guidelines from allergic disease-specific expert groups were included. Results: People with asthma and other chronic respiratory conditions are at higher risk of negative psychological outcomes, and risk factors include asthma severity, female sex, and previous history of anxiety and depression, likely owing to the perceived risk of severe disease from COVID-19. One study identified that people with allergic rhinitis had significantly high anxiety and depression scores compared with healthy controls (both, P < .001). The psychological impacts of food allergy during COVID-19 were most strongly felt by parents and caregivers. Similarly, parents of children with asthma experienced substantial psychological burden. Conclusion: COVID-19 had a considerable psychological impact on patients with asthma. Limited data have been published on the mental health impacts of COVID-19 on patients with allergic rhinitis and food allergy. As COVID-19 research continues to evolve and the literature captures later stages of the pandemic, it is important that physicians be aware of the potential coincidence of mental illness and chronic allergic diseases and refer these patients, and their caregivers, to appropriate resources while also continuing to manage their allergic disease(s).

show abstract

“…However, studies have found no significant impact on route to diagnosis and severity of presentation for type 1 diabetes and new diagnosed cancers, as well as no impact on overall outcomes for asthma, pyloric stenosis and appendicitis. [10][11][12][13][14] There have also been concerns that some CYP were unable to access specialist services in hospitals. For example, a study of radiology outpatient activity at a tertiary children's hospital from March 2020 to March 2021 showed a reduction of 27.3%.…”

Section: Introductionmentioning

confidence: 99%

Impact of COVID-19 on outpatient appointments in children and young people in England: an observational study

et al. 2022

View full text Add to dashboard Cite

ObjectivesTo describe the impact of the COVID-19 pandemic on outpatient appointments for children and young people.SettingAll National Health Service (public) hospitals in England.ParticipantsAll people in England aged <25 years.Outcome measuresOutpatient department attendance numbers, rates and modes (face to face vs telephone) by age group, sex and socioeconomic deprivation.ResultsCompared with the average for January 2017 to December 2019, there was a 3.8 million appointment shortfall (23.5%) for the under-25 population in England between March 2020 and February 2021, despite a total rise in phone appointments of 2.6 million during that time. This was true for each age group, sex and deprivation fifth, but there were smaller decreases in face to face and total appointments for babies under 1 year. For all ages combined, around one in six first and one in four follow-up appointments were by phone in the most recent period. The proportion of appointments attended was high, at over 95% for telephone and over 90% for face-to-face appointments for all ages.ConclusionsCOVID-19 led to a dramatic fall in total outpatient appointments and a large rise in the proportion of those appointments conducted by telephone. The impact that this has had on patient outcomes is still unknown. The differential impact of COVID-19 on outpatient activity in different sociodemographic groups may also inform design of paediatric outpatient services in the post-COVID period.

show abstract

Evaluation of the impact of shielding to avoid COVID-19 infection on respiratory symptoms in children with severe asthma

Cited by 4 publications

References 2 publications

Effect of the SARS-CoV-2 pandemic on the control and severity of pediatric asthma

Effect of the SARS-CoV-2 pandemic on the control and severity of pediatric asthma

Psychological impacts of coronavirus disease 2019 on people with asthma, allergic rhinitis, and food allergy

Impact of COVID-19 on outpatient appointments in children and young people in England: an observational study

Contact Info

Product

Resources

About